9-134780147-G-C
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PVS1_ModeratePM2PP5_Very_Strong
The NM_000093.5(COL5A1):c.2430+1G>C variant causes a splice donor, intron change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_000093.5 splice_donor, intron
Scores
Clinical Significance
Conservation
Publications
- Ehlers-Danlos syndromeInheritance: AD Classification: DEFINITIVE Submitted by: G2P
- Ehlers-Danlos syndrome, classic typeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, Ambry Genetics, PanelApp Australia, Genomics England PanelApp
- Ehlers-Danlos syndrome, classic type, 1Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- arterial disorderInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| COL5A1 | NM_000093.5 | c.2430+1G>C | splice_donor_variant, intron_variant | Intron 28 of 65 | ENST00000371817.8 | NP_000084.3 | ||
| COL5A1 | NM_001278074.1 | c.2430+1G>C | splice_donor_variant, intron_variant | Intron 28 of 65 | NP_001265003.1 | |||
| COL5A1 | XM_017014266.3 | c.2430+1G>C | splice_donor_variant, intron_variant | Intron 28 of 64 | XP_016869755.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| COL5A1 | ENST00000371817.8 | c.2430+1G>C | splice_donor_variant, intron_variant | Intron 28 of 65 | 1 | NM_000093.5 | ENSP00000360882.3 | |||
| COL5A1 | ENST00000371820.4 | c.2430+1G>C | splice_donor_variant, intron_variant | Intron 28 of 65 | 2 | ENSP00000360885.4 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Ehlers-Danlos syndrome, classic type, 1 Pathogenic:2
This sequence change affects a donor splice site in intron 28 of the COL5A1 gene. RNA analysis indicates that disruption of this splice site induces altered splicing and may result in an absent or disrupted protein product. This variant is not present in population databases (gnomAD no frequency). Disruption of this splice site has been observed in individuals with Ehlers-Danlos syndrome (PMID: 10777716, 22696272). It has also been observed to segregate with disease in related individuals. Studies have shown that disruption of this splice site results in inclusion of part of intron 28 and introduces a premature termination codon (PMID: 10777716). The resulting mRNA is expected to undergo nonsense-mediated decay. For these reasons, this variant has been classified as Pathogenic. -
The variant is not listed in gnomAD. It has not yet been described in the literature or in the ClinVar database. However, another base pair exchange (c.2430+1G>A, rs1060502248) is already deposited as pathogenic in ClinVar at the same location. Bioinformatically, various prediction programs (SSF, MaxEnt, GeneSplicer) predict a likely effect on the splice donor site for the variant. Variants affecting the canonical splice site of a gene matching the phenotype and inheritance, where "loss of function" alterations are a known pathomechanism, are very likely to have pathogenetic relevance. At this stage, the variant has been classified as "pathogenic". -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at